GoodRx launches new $39 per month weight loss telemedicine subscription
End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment.
End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment.
“FMI is grateful and extremely pleased at President’s Trump’s actions to cut tariffs on a wide swathe of food and agriculture products."
Pharmacies are taking full advantage of the opportunity to optimize the management of this chronic condition that is growing ever more widespread.
David Pinto looks at the five major changes in the mass retail market and what we did to reflect those changes
By Thom Blischok, chairman and chief executive officer of the Dialogic Group LLC.
CRN emphasized that the ruling does not address the merits of its First Amendment claims.
This technology allows for easier injection with smaller needles and more consistent drug concentrations.
Her responsibilities will include product creation and management of the nonprofit's online store, overseeing design and visual content, video production and content scheduling.
Veteran merchant credited with driving pOpshelf expansion and digital innovation takes on expanded operational role
Titled “Operation: Gingerbread,” this year’s film features Kroger’s animated Krojis to tell a story of creativity, connection, and homecoming.
Stores offer a variety of health resources and pharmacy services to keep communities healthy year-round.
For over 30 years, the company has built its reputation on originality, artistry, and quality—values central to its 2027 calendar, planner collections, and RSVP alternative greeting cards.
The retailer recognized 12 outstanding associates with the George W. Jenkins and President’s awards.
By William M. Simpson is the president and CEO of DisposeRx, Inc.
The U.S. Mint has struck its final pennies, ending over 230 years of production and accelerating a transition causing cash-handling issues cited by retailers.
Ingenus called the approval and launch “a major milestone” in the company’s growing women’s health and complex generics portfolio.